Dr. Ilyas Sahin
Claim this profileUniversity of Florida Health Science Center - Gainesville
Studies Cancer
Studies Hepatocellular Carcinoma
4 reported clinical trials
12 drugs studied
Area of expertise
1Cancer
Stage III
Stage IV
2Hepatocellular Carcinoma
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Ilyas Sahin is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting1 award Phase 2 & 3
More about Ilyas Sahin
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ilyas Sahin has experience with
- MFOLFIRINOX
- Atezolizumab
- Bevacizumab
- SRF388
- Placebo
- CTX-009
Breakdown of trials Ilyas Sahin has run
Hepatocellular Carcinoma
Gallbladder Cancer
Biliary Tract Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ilyas Sahin specialize in?
Ilyas Sahin focuses on Cancer and Hepatocellular Carcinoma. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Ilyas Sahin currently recruiting for clinical trials?
Yes, Ilyas Sahin is currently recruiting for 3 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Ilyas Sahin has studied deeply?
Yes, Ilyas Sahin has studied treatments such as mFOLFIRINOX, Atezolizumab, Bevacizumab.
What is the best way to schedule an appointment with Ilyas Sahin?
Apply for one of the trials that Ilyas Sahin is conducting.
What is the office address of Ilyas Sahin?
The office of Ilyas Sahin is located at: University of Florida Health Science Center - Gainesville, Gainesville, Florida 32610 United States. This is the address for their practice at the University of Florida Health Science Center - Gainesville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.